Archive for March, 2011


FDA Consumer Health Feed: Bad Reaction to Cosmetics? Tell FDA

Have you had a negative reaction to a hair dye or makeup, body wash or lotion? If you have, FDA’s office of cosmetics wants you to report it. FDA Consumer Health Information Updates

Read More...

FDA Mediation Watch: Pradaxa (dabigatran etexilate mesylate) Capsules: Special Storage and Handling Requirements

Potential for product breakdown and loss of potency if not dispensed and stored in the original bottle or blister package. MedWatch Safety Alert RSS Feed

Read More...

FDA Press Releases: FDA Issues Statement on Makena

On February 3, 2011, the Food and Drug Administration approved the drug Makena (hydroxyprogesterone caproate) for the reduction of the risk of certain preterm births in women who have had at least one prior preterm birth. KV Pharmaceuticals, the drug’s owner, received considerable assistance from the federal government in connection with the development of Makena [...]

Read More...

FDA New Drugs Feed: FDA Drug Safety Communication: Special storage and handling requirements must be followed for Pradaxa (dabigatran etexilate mesylate) capsules

[03-29-2011] The U.S. Food and Drug Administration (FDA) is alerting the public to important storage and handling requirements for Pradaxa (dabigatran etexilate mesylate) capsules. What’s New: Drugs RSS Feed

Read More...

FDA Recall Alerts: USA Far Ocean Group Inc. Issues Voluntary Nationwide Recall of X-Hero and Male Enhancer, Products Marketed as Dietary Supplements

X-Hero and Male Enhancer Dietary Supplements Food and Drug Administration–Recalls/Safety Alerts

Read More...